booksshare.net -> -> -> . -> " " -> 159

- .

. .: , 2007. 608 c.
ISBN 5-98657-009-
( ): pharmazeutischewirkstoffe1982.djvu
<< 1 .. 153 154 155 156 157 158 < 159 > 160 161 162 163 164 165 .. 345 >>

4CH3
Levomepromazin
Levaru® (Mohan) Levomezine® (Toho) Levotomin® (Yoshitomi) Sofmin® (Dainippon) USA: Levoprome® (Lederle)
Levonorgestrel
(D-Norgestrel; Dexnorgestrel)
797-63-7
Gestagen
d-(—)-l 3-ethyl- 17-hydroxy- 18,19-dinor-17a-pregn-4-en-20-yn-3-one
C2Hs
H2C = CH-MgCl
H3C0'
6-Methoxy-l-tetralon Vinylmagnesium-chlorid
H3C0‘
H2C
И
не он
,j05
HsC2 0
H3C0'
Saccharomyces uvarurr
H3CO'
Aethdion
(2-Ethylcyelfi-
pentan-l,3-<lion)
I (HjC-C0)20/[Pyridiri] 2. H3C^S03H
H3CO'
О—СО—CH3
2. KOH/CHlOH
3. Li/NH3/^^>— Nbj
2. Kadumhydroxid
3. Lithium /Anitin
H3CO'
1 А1[осн(снз)2]з;нзс-со-с2н5 J
2 Li-CSCH 1
3 HCl_
1 Aluminiumtmsopropylat у Methyiethylketon !
2 Lithumacetytid _ 0"
OH
CECH
Levonorgestrel
524 L Levonorgestrel - Levorphanol
C. Rufer et al., Justus Liebigs Ann. Chem. 702,141 (1967).
Weitere Verfahren:
DOS 1806410 (Hoffmann-LaRoche; Anm. 31.10.1968; USA-Prior. 2.11,1967). H. Smith et al., J. Chem. Soc. 1964,4472.
Ethinylierungsverf ahren:
DDR-P 114807 (Reihe, Kutz; Anm. 11.10.1974).
DBP 2030 056 (Schering AG; Anm. 13.7.1970).
Anwendung als Kontrazeptivum:
DOS 1922 005 (Schering AG; Anm. 24.4.1969). in Kombination mit 17a-Ethinylestradiol als Kontrazeptivum:
DOS 2 218 831 (Schering AG; Anm. 14.4.1972).
DOS 2335 265 (Schering AG; Anm. 30.1.1975).
DAS 2 365 103 (Schering AG; Anm. 21.12.1973),
DOS 2431 704 (Asche; Anm. 2.7.1974).
Intrauterine Anticonception:
DOS 2 361206 (Schering AG; Anm. 6.12.1973).
Galenische Zubereitung:
DOS 2432925 (Schering AG; Anm. 5.7.1974).
DOS2449 865 (Schering AG; Anm. 17.10.1974).
D: Ediwal® 21 (Schering)-Komb. Microgynon® (Schering)-Komb. Microluf® (Schering) Micro-30-Wyeth® (Wyeth) Neogynon® (Schermg)-Komb. Neo-Stediril® (Wyeth)-Komb. Perikursal® 21 (Wyeth)-Komb. Sequilar8 21,28 (Wyeth)-Komb. Stediril®d (Wyeth)-Komb. Terminolut® (Schering)-Komb. Triquilar® (Schering)-Komb.
F: Adepal® (Wyeth-Byla)-Komb. Microval (Wyeth-Byla)
Minidril (Wyeth-Byla)-Komb.
GB: Eugynon® 30 (Schering)-Komb. Logynon® (Schering)-Komb. Microgynon® 30 (Schering)-Komb. Microval® (Wyeth)
Norgeston (Schering)
Ovran® 30 (Wyeth)-Komb. Ovranette® (Wyeth)-Komb. Trinordiol® (Wyeth)-Komb.
I: Egogyn® (Schering)-Komb.
Microgynon® (Schenng)-Komb. Ovranet® (Wyeth)-Komb.
Levorphanol
77-07-6
125-72-4
Analgeticum
Tarlrat
(— )-3-hydroxy-N-methylmorphinan
Cf
COOH
I
h2c-cn
[H3C-C00NHJ
.a
COOH
CH-CN
Cyclo- Cyanessig-
hexanon saure
ac
nCN
1-Cyciohexenyl-
acetonitril
QTCH>
NH-?
2-|1-Cyclohexenylb
ethylamin
D-0"CI
4-Melho»yphenyl -acetylchtond
CH2
O'
ОСНз
4-Methoxyphenylessigsaure-
[2-(1-cydohexenyt)-ethylamidl
Levorphanol - Levothyroxin L 525
1 CH20
^ 2. Hj/Raney-Ni
kJCjSN H,/Raney-Ni, CJC'N
сн^~О“0снз сн2_<Он'
Mi-MethoxybenzyO-3/,5,6, 44-MethoxybenzyiH,2,3,4,
7,8-hexahydroisochinolin 5,6,7,8-octahydroisochinolin
OCH3
H3CO
l-(4-Methoxybenzyl]-2-methyt-
1,2l3,4,5l6,7J8-octahydroi5oehinotin
{i )-3-Hydroxy-W-methyirriorphinan
Ehrhart, Ruschig 1,130-131.
O. Schnider, J. Hellerbach, Helv. Chim. Acta 33,1437 (1950).
O. Schnider, A. Griissner, Helv. Chim. Acta 34, 2211 (1951).
D: Dromoran® (Roche) USA: Levo-Dromoran® (Roche)
GB: DromoTan® (Roche)
LeVOthyrOXin 51-48-9 Schilddriisenhormon
55-03-8 Na-Salz
i-3-[4-(4-hydroxy-3>5-diiodo-phenoxy)-3>5-diiodophenyl]aIanine
L - ( + )— Л/— Focrnyl - 3,5 -dijodthyromn i-{+)-3,5-Dijodthyronin
<vgl. Dextrothyroxm-Synthese. s. S. 266)
I I
Levothyrcwn
H. Nahm u. W. Siedel, Chem. Ber. 96,1 (1963). DBP 1 067 826 (Hoechst; Anm. 1955).
DBP 1077 673 (Hoechst; Anm. 1958).
526 L Levothyroxin - Lidocain - Lidoflazin
Alternativ-Verfahren aus L-Tyrosin liber L-/V-Acetvl-3,5-dijod-tyrosinethvlester: DBP 1 064 529 (G. Hillmann; Anm. 1956).
DBP 1065 855 (G. Hillmann; Anm. 1956).
USP 2 803 654 (Baxter Labs.; ert. 1957; Prior. 1953).
USP2889 363 (Baxter Labs.; ert. 1959; Anm. 1955).
USP 2 889 364 (Baxter Labs.; ert. 1959; Anm. 1957).
D: Euthyrox® (Merck)
L-Thyroxin ,,Henning“ (Henning Berlin) Thevier® (Glaxo)
F: Percutacrine Thyroxinique (Besins-Iscovesco)
GB: Eltroxin® (Glaxo)
J: Thyradin®-S (Teikoku Zoki) USA: Letter® (Armour) Synthroid® (Flint)
Lidocain
(Lignocaine)
137-58-6
73-78-9
Hydrochlorid
Lokalanastheticum;
Antiarrhythmicum
2-diethylamino-2',6'-acetoxylidide
CH3
<^NH2 * Cl—С—CH2—Cl
2,6-Dimethyl-
anilin
Chtoracetyl-
-nlond
/=(СНз Я
<{ ^-nh-c-ch2-ci ch3
a-Chlor-2,6-dimethyl-
acetanilid
/ан6
nc2h5
CH3
C,H.
2ns :
NH-C-CH,-N II 2 0
4c,H,
CH3 u
Lidocain
USP 2 441 498 (AB Astra; ert. 1948; S-Prior. 1943).
DBP 968 561 (AB Astra; Anm. 1944; S-Prior. 1943).
Hydrochlorid-Monohydrat:
USP 2 797241 (C. L. M. Brown u. A. Poole; ert. 1957; GB-Prior. 1953).
D: Lidocain-Losung (Pfrimmer)
Neo-Novutox® (Braun Melsungen)
Xylestesin®-Salbe (Espe)
Xylocain® (Astra Chemicals)
Xyloneural® (Nicholas)
F: Xylocaine® (Roger Bellon)
Xylocard® (Roger Bellon) zahlreiche Komb.-Praparate
<< 1 .. 153 154 155 156 157 158 < 159 > 160 161 162 163 164 165 .. 345 >>

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed

, ?
2009 BooksShare.
.
Rambler's Top100

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed